Skip to main content
Philogen logo

Philogen — Investor Relations & Filings

Ticker · PHIL ISIN · IT0005373789 LEI · 81560009EA1577917768 XMIL Manufacturing
Open in API
Filings indexed 377 across all filing types
Latest filing 2021-04-30 Remuneration Information
Country IT Italy
Listing XMIL PHIL

About Philogen

https://www.philogen.com

Philogen is a clinical-stage biotechnology company focused on the discovery and development of novel biopharmaceutical products for the treatment of cancer and other serious conditions associated with angiogenesis. Founded in 1996, the company's core strategy is based on innovating targeted therapies, such as antibody-cytokine fusions, which are designed to selectively deliver therapeutic agents to the site of disease. This approach aims to increase efficacy while reducing toxicity. Philogen operates as an integrated company with capabilities in research, GMP manufacturing, and clinical development of its proprietary product pipeline.

Recent filings

Filing Released Lang Actions
Philogen - Relazione sulla remunerazione
Remuneration Information Classification · 99% confidence The document title is "RELAZIONE SULLA POLITICA IN MATERIA DI REMUNERAZIONE E SUI COMPENSI CORRISPOSTI - ESERCIZIO 2020" (Report on Remuneration Policy and Compensation Paid - Fiscal Year 2020). The text explicitly references Italian regulations (art. 123-ter D. Lgs. 58, Regolamento Consob n. 11971) and details the structure of the report into Section I (Remuneration Policy) and Section II (Compensation Paid for FY 2020). This content directly corresponds to the definition of a Remuneration Report, which in the provided list maps to 'Remuneration Information' (Code: DEF 14A), as this category covers reports detailing compensation for top executives and directors, which is the primary focus of this Italian regulatory document.
2021-04-30 Italian
Philogen - Relazione sul governo societario e gli assetti proprietari
Governance Information Classification · 98% confidence The document is explicitly titled "RELAZIONE ANNUALE SUL GOVERNO SOCIETARIO E GLI ASSETTI PROPRIETARI - ESERCIZIO 2020" (Annual Report on Corporate Governance and Ownership Structure - Fiscal Year 2020) and states it is prepared pursuant to art. 123-bis of the TUF (Testo Unico della Finanza). This content structure, focusing heavily on corporate governance, board composition, shareholder structure, and compliance with specific Italian regulatory articles (like 123-bis), strongly aligns with the requirements for a Corporate Governance Report, which is best categorized under Governance Information (CGR) in the provided schema, as it details internal rules, board structure, and governance practices, rather than being a full financial 10-K or a simple announcement (RPA/RNS). Although it covers the fiscal year 2020, its primary focus is governance structure, not the financial results themselves.
2021-04-30 Italian
Philogen - Documento informativo - Piano di Stock Grant Grant 2024-2026
Remuneration Information Classification · 95% confidence The document is titled "DOCUMENTO INFORMATIVO RELATIVO AL PIANO DI INCENTIVAZIONE DI PHILOGEN S.P.A. DENOMINATO 'PIANO DI STOCK GRANT 2024-2026'" (Informative Document relating to the Incentive Plan...). It explicitly references Italian regulatory articles concerning issuer regulations (art. 114-bis of Legislative Decree 58/1998 and art. 84-bis of the Issuers' Regulation adopted by Consob). This type of detailed document, outlining the structure, beneficiaries, rationale, and terms of a stock-based incentive plan for management and employees, aligns perfectly with the description of a document detailing compensation and incentive structures, which is closely related to Remuneration Information (DEF 14A) or Governance Information (CGR). However, given the specific focus on a 'Piano di Incentivazione' (Incentive Plan) detailing compensation instruments, it is most analogous to the US DEF 14A (Proxy Statement detailing compensation) or a specialized governance/remuneration filing. Since the provided definitions do not have a specific code for 'Stock Incentive Plan Document,' I must choose the closest fit. DEF 14A covers remuneration information. Alternatively, CGR covers internal rules and board structure. Since this document is highly specific about compensation mechanics (Units, vesting, performance variables), DEF 14A (Remuneration Information) is the strongest conceptual match, even though it is an Italian filing. Revisiting the definitions: DEF 14A is 'Remuneration Information: Report detailing compensation for top executives and directors.' This document is a comprehensive plan detailing compensation via stock grants for management and employees. This is a very strong fit for remuneration disclosure. If this were a simple announcement of the plan's approval, RPA or RNS might apply, but the document length (56k chars) and detailed index suggest it is the full informative document itself, not just an announcement of its publication.
2021-04-30 Italian
relazione finanziaria annuale 2020
Annual Report Classification · 100% confidence The document is a comprehensive annual report for Philogen, as evidenced by the table of contents which includes 'Relazione sulla gestione' (Management Report), 'Bilancio consolidato' (Consolidated Financial Statements), 'Conto economico' (Income Statement), 'Stato patrimoniale' (Balance Sheet), and 'Rendiconto finanziario' (Cash Flow Statement) for the fiscal year ending 31.12.2020. It covers the full scope of company activity, financial performance, and governance, fitting the definition of an Annual Report (10-K). FY 2020
2021-04-30 Italian
THE BOARD OF DIRECTORS APPROVES THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS OF 31 DECEMBER 2020
Earnings Release Classification · 95% confidence The document is an official announcement from Philogen S.p.A. detailing the approval of draft financial statements for the year ended 31 December 2020. It provides key financial highlights (Revenue, EBITDA, EBIT, Net Loss), a variance analysis between forecast and actual data, and information regarding board resolutions (Incentive Plan, Shareholders' Meeting). While it contains substantive financial data, it is structured as a press release/announcement of results rather than the full, formal audited Annual Report (10-K equivalent). Given the detailed financial performance summary and management commentary, it fits the definition of an Earnings Release (ER) as it serves as the initial announcement of periodical financial results. FY 2020
2021-04-27 English
IL CONSIGLIO DI AMMINISTRAZIONE APPROVA IL PROGETTO DI BILANCIO DI ESERCIZIO E IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2020
Earnings Release Classification · 95% confidence The document is a press release from Philogen S.p.A. announcing the approval of its draft financial statements and consolidated financial statements for the year ended December 31, 2020. It provides key financial highlights (Revenue, EBITDA, EBIT, Net Result, Net Financial Position) and compares them to the previous year. While it contains substantive financial data, it is structured as an initial announcement of results (Earnings Release) rather than the full, audited Annual Report document itself. It also includes information on board resolutions regarding incentive plans and upcoming shareholder meetings, which is typical for an earnings release announcement. FY 2020
2021-04-27 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.